A survey and evaluation of population-based screening for gastric cancer

Cancer Biology and Medicine

Volumn 10, Issue 2, 2013, Pages 72-80

  Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Endoscopy; Evaluation studies; Gastric cancer; Pepsinogen; Screening

Indexed keywords

BARIUM; BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GASTRIN 17; PEPSINOGEN I; PEPSINOGEN II;

CANCER SCREENING; DOUBLE CONTRAST RADIOGRAPHY; ENDOSCOPY; HEALTH CARE COST; HEALTH CARE SURVEY; HUMAN; REVIEW; STOMACH CANCER; TUMOR BIOPSY;

EID: 84882978991     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2013.02.002     Document Type: Review

References (44)

1. Jemal A, Bray F, Center M M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Chen Z. eds. The Third National Retrospective Sampling Death Survey. Beijing: Peking Union Medical College Press, 2008.
3. Shirakabe H. eds. Double contrast studies of the stomach. Tokyo: Igaku Shoin, 1970
4. Hisamichi S. Screening for gastric cancer. World J Surg 1989;13:31-37.
5. Lambert R. Endoscopy in screening for digestive cancer. World J Gastrointest Endosc 2012;4:518-525.
6. Samloff I M. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982;82:26-33.
7. Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 2006;163:629-637.
8. Yuan Y, Zhang Y C. A Report of Prevention and Control Scene for Gastric Cancer in Zhuanghe Region, Liaoning Province. Zhongguo Zhongliu 2009;18:13-17.
9. Matsushima M, Miki K, Ichinose M, Kakei N, Yahagi N, Suzuki T, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. In: Takahashi K. eds. Aspartic Proteinases: Advances in Experimental Medicine and Biology. New York: Plenum Press, 1995:139-143.
10. Sipponen P. Biomarkers in clinical practice: a tool to find subjects at high risk for stomach cancer. A personal view. Adv Med Sci 2006;51:51-53.
11. Dong Z W. eds. Screening, early detection and treatment of cancer in China. Beijing: People's Medical Publishing House, 2009.
12. Early detection and treatment of cancer committee. Technical solution on early detection and treatment of cancer in China. Beijing: People's Medical Publishing House, 2011.
13. Leung W K, Wu M S, Kakugawa Y, Kim J J, Yeoh K G, Goh K L, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008;9:279-287.
14. Fan D M, Zhang X Y, Chen X T, Mu Z X, Hu J L, Qiao T D, et al. Mouse and human monoclonal antibodies against gastric cancer. Preparation and clinical application. Chin Med J (Engl) 1988;101:488-489.
15. Ren J, Chen Z, Juan S J, Yong X Y, Pan B R, Fan D M. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer 2000;88:280-285.
16. Zhang L, Ren J, Pan K, Ma J, Li J, Shen L, et al. Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening. Int J Cancer 2010;126:469-473.
17. You W C. Progress in early detection and treatment for gastric cancer. Zhongguo Zhong Liu 2009;18:695-699.
18. Jin B, Wang X, Jin Y, Xia W, Chen B, Liu L, et al. Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. Cancer Invest 2009;27:227-233.
19. Lin H Z, Chen L, Li X C, Zhou D F, Cui J Y. The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer. Zhonghua Wai Ke Za Zhi 2004;42:1505-1508.
20. Eroǧlu A. Serum levels of vascular endothelial growth factor in gastric cancer patients. J Surg Oncol 2011;104:222.
21. Tanaka K, Miki C, Wakuda R, Kobayashi M, Tonouchi H, Kusunoki M. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma. Scand J Gastroenterol 2004;39:7547-60.
22. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
23. Fock K M, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23:351-365.
24. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-768.
25. Fitzgerald R C, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010;47:436-444.
26. Boccia S, Sayed-Tabatabaei F A, Persiani R, Gianfagna F, Rausei S, Arzani D, et al. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 2007;7:206.
27. Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudicce G, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol 2008;37:1316-1325.
28. Murphy G, Thornton J, McManus R, Swan N, Ryan B, Hughes D J, et al. Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol 2009;21:630-635.
29. Xu Q, Yuan Y, Sun L P, Gong Y H, Xu Y, Yu X W, et al. Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol 2009;35:1313-1320.
30. Gao L, Nieters A, Brenner H. Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. Eur J Hum Genet 2009;17:1658-1667.
31. Smith R A, Cokkinides V, Brooks D, Saslow D, Brawley O W. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010;60:99-119.
32. Dong Z W, Qiao Y L, Wang G Q. Evaluation of early diagnosis and treatment of cancer. Zhonghua Zhong Liu Za Zhi 2012;34:637-640.
33. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008;38:259-267.
34. Nakajima S. Gastric cancer screening in Japan, now and tomorrow. Nihon Rinsho 2012;70:1686-1693.
35. Miki K, Ichinose M, Kawamura N, Matsushima M, Ahmad H B, Kimura M, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111-114.
36. Choi I J. Screening and surveillance of gastric cancer. Korean J Gastroenterol 2007;49:15-22.
37. Jung K W, Park S, Kong H J, Won Y J, Boo Y K, Shin H R, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010;25:1113-1121.
38. National Registry of Diseases Office. Singapore Cancer Registry Interim Report. Trends in cancer incidence in Singapore 2001-2005.
39. Ding S G, Wang J S, Lin S R, Zhao Y M, Zhou L Y. Sequence screening for declining the mortality of gastric cancer. Zhongguo Zhong Liu Lin Chuang Yu Kang Fu 2001;8:38-40.
40. Yuan Y. Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 2011. Zhonghua Zhong Liu Za Zhi 2012;34:538-542.
41. Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, et al. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer 2012;130:1614-1619.
42. Goldie S J, Gaffikin L, Goldhaber-Fiebert J D, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-2168.
43. Dan Y Y, So J B, Yeoh K G. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol 2006;4:709-716.
44. Zhou L, Guan P, Sun L P, He Q C, Yuan Y, Zhou B S. Health economic assessment for screening of gastric cancer in a high risk population in northeastern china. Chin J Cancer Res 2011;23:21-24.